Schaeffer's Top Stock Picks for '25

Analysts Are Buying This Biotech's Sell-Off

Karyopharm Therapeutics bounced near the $10 level in recent weeks

Nov 9, 2018 at 1:55 PM
facebook X logo linkedin


Yesterday, Karyopharm Therapeutics Inc (NASDAQ:KPTI) closed down 3.1% following the company's third-quarter results. However, not everyone's throwing in the towel on KPTI. In fact, Wedbush just moved in and upgraded the shares to "outperform" from "neutral" based on its belief that the shares are at an "attractive entry point." And though it trimmed its price target to $24 from $25, RBC is staying positive on the equity.

Most other analysts are already very bullish on the security, with six of the eight in coverage handing out "strong buy" recommendations. Also, the average 12-month price target of $23.90 is more than double the shares' price today of $11.76.

Looking elsewhere, however, many are gearing up for more downside for KPTI. Short interest jumped by 33.9% in the last reporting period. This puts 13.8% of the total float in the hands of short sellers, which would take 6.5 sessions to cover, based on average daily volumes.

Looking closer at Karyopharm Therapeutics' chart, the stock has struggled in recent months, falling from an Aug. 30 three-year high of $21.71, recently bottoming near the round $10 level, a price point that also acted as a floor back in January. Also, the 20-day moving average is starting to flatten, hinting at a potential trend change for KPTI.

kpti stock price

 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?

 

 

(function(doc, script) { var js, fjs = doc.getElementsByTagName(script)[0], frag = doc.createDocumentFragment(), add = function(url, id) { if (doc.getElementById(id)) {return;} js = doc.createElement(script); js.src = url; id && (js.id = id); frag.appendChild( js ); }; // Google+ button //add('https://apis.google.com/js/platform.js', async="defer"); // Facebook SDK add('//connect.facebook.net/en_US/all.js#xfbml=1&appId=772755279557744', 'facebook-jssdk'); // Twitter SDK //add('//platform.twitter.com/widgets.js', charset='utf-8'); fjs.parentNode.insertBefore(frag, fjs); }(document, 'script'));